Immunoradiometric and Luminescence Immunoenzymometric Assay of Human Thyrotropin from Dried Blood Spots for Screening of Neonatal Hypothyroidism by Jirkalová, Veleslava et al.
Eur J Clin Chem Clin Biochem 1996; 34:823-827 © 1996 by Walter de Gruyter · Berlin · New York
Immunoradiometric and Luminescence Immunoenzymometric Assay of
Human Thyrotropin from Dried Blood Spots for Screening of Neonatal
Hypothyroidism
Veleslava Jirkalova1, Jan Cap1, Hana Strakova2, Jaroslava PribySova1, Jan Plickc? and Radovan Lomsky1
1
 Centrum pro hormonalni proteiny a peptidy, Lekafska fakulta Karlovy university a Fakultni nemocnice,
Hradec Kralove, Ceska republika
2
 Tkänovä ustfedna, Fakultni nemocnice, Hradec Krälove, Ceskä republika
3
 Immunotech a. s., Praha, Ceska republika
Summary: Two monoclonal antibodies to thyrotropin prepared in our laboratory were employed for the develop-
ment of two-site immunometric assays in two modifications for the estimation of human thyrotropin in dried blood
spots designed for the screening of neonatal hypothyroidism. The immunoradiometric assay using the second anti-
body labelled with I25I is simple and fast (one incubation step lasting 2 h). The detection limit of 1 mU/1 and the
absence of the hook effect up to a concentration of more than 1000mU/l are optimal for neonatal screening; the
presence of other glycoprotein hormones does not interfere with the assay. In the luminescence immunoenzymo-
metric assay the second antibody is labelled with peroxidase. In spite of the two-step configuration the method is
fast (4.5 h) and enables specific determination of thyrotropin levels in the range of 2.4-1100 mU/1. The conditions
and properties of both immunometric assays described are comparable with the time-resolved immunofluorometric
assay widely used in Europe.
The luminescence immunoenzymometric assay was applied successfully in the screening of 3000 neonates for
congenital hypothyroidism.
Introduction
The incidence of neonatal hypothyroidism in the USA and
in Europe is 1/4000, with differences in European coun-
tries from 1/3000 to 1/6000 (1). The determination of the
level of thyrotropin in dried blood spots is now widely
considered to be the optimal method for the screening of
neonatal hypothyroidism (2). For this purpose a number
of methods have been developed and immunometric as-
says based on two antibodies have been used almost ex-
clusively in the past ten years. The combinations used in-
volved two polyclonal antibodies (3—5), one monoclonal
and one polyclonal antibody (6) and, most recently, a pair
of monoclonal antibodies (7—10).
In this study we present a simple, rapid, specific and
sensitive immunoradiometric assay and its non-isotopic
variety — the luminescence immunoenzymometric assay
— for the measurement of thyrotropin in dried blood
spots for the screening of neonatal hypothyroidism using
our own monoclonal antibodies to thyrotropin.
Materials and Methods
Hormones
The starting material for the isolation of human thyrotropin was
the glycoprotein fraction obtained from frozen pituitaries using the
method of Lumley Jones et al. (11). Following precipitation at a
final ethanol volume fraction of 0.75, the precipitate was dissolved
in 100 mmol/1 NH4HC03 and applied to a column of Sephacryl S-
100 HR. The glycoprotein hormone-containing fractions were
pooled and freeze-dried. Thyrotropin was isolated from the freeze-
dried material by consecutive chromatography on S-Sepharose Fast
Flow, DEAE-cellulose (DE-52 Whatman), CM-cellulose (CM-52
Whatman), and Sephadex G-100 Superfine. All chromatographies
were monitored using RIA for thyrotropin, follitropin, and lutropin.
The resulting preparation of thyrotropin had an immunologic activ-
ity of 8.1 U/mg when measured in an IRMA system against the
second TRP 80/558 and it contained only negligible traces of folli-
tropin and lutropin.
Human somatotropin was isolated from frozen pituitaries by a
modification of the method of Lumley Jones et al. (11). The
resultant preparation of somatotropin had a specific potency of
3.1 U/mg when measured by RIA against the first IRP 66/217.
Human prolactin was isolated from frozen pituitaries by a modi-
fication of the method of Hwang et al. (12) and had a potency
of 31.16 U/mg when measured by RIA against the third IS
84/500.
Second IS 80/552 was used as the standard for human lutropin,
first IS 83/575 was used as the standard for human follitropin
and third IS 75/537 was used as the standard for human chori-
onic gonadotropin.
Monoclonal ant ibodies
Using methods found in the literature (13) we prepared 273 mouse
monoclonal antibodies to thyrotropin. For the construction of the
immunometric systems, two antibodies were chosen that could
bind the thyrotropin (TSH) molecule simultaneously. The TSH-51
824 Jirkalova et al.: Assay of thyrotropin forscreening of neonatal hypothyroidism
antibody of an lgG2a subclass is strictly specific for thyrotropin
with an association constant of 5.5 X 1010 1/mol and has a strong
capacity to bind the hormone on the solid phase. The TSH-116
antibody of an IgG2a subclass binds the -subunit of thyrotropin
with an association constant of 1.1 X 10" 1/mol. It cross-reacts
considerably with other glycoprotein hormones, which is of no sig-
nificance in the present configuration of the assay system (see be-
low). Both antibodies have a high speed of reaction. The isolation
of antibodies from ascitic fluid was performed by chromatography
on a column of Protein-Α Sepharose CL-4B (14).
Preparat ion of s tandards
Standards for immunoradiometric assay (IRMA) were prepared by
adding the international reference preparation of thyrotropin (se-
cond IRP 80/558) in concentrations of 0, 5, 15, 30, 80 and 160
mU/1 to heparinized blood with a thyrotropin content lower than
0.05 mU/1. After thorough mixing, blood-spots were prepared on
Schleicher-Schuell No. 2992 filter paper. After drying at room tem-
perature for 4 h the standards were stored at 4 °C.
For the investigation of the cross-reactions, spots of blood with
200 μg/l prolactin, 100 μg/l somatotropin, 100 U/l chorionic
gonadotropin, 100 U/l lutropin and 100 U/l follitropin were
prepared. These hormones were added both to blood with zero
concentration of thyrotropin and to blood containing 36 mU/1
thyrotropin.
Standards for luminescence immunoenzymometric assay were pre-
pared by adding thyrotropin in 10 mmol/1 phosphate buffer, pH 7.4,
to a special matrix consisting of human serum (with thyrotropin
concentration lower than 0.03 mU/1) mixed with erythrocytes to
give a physiological haematocrit ratio, the volume of the buffered
thyrotropin standard not exceeding 5% of the matrix. Standards
with thyrotropin concentrations of 0, 12, 30, 70 and 160 mU/1,
respectively, were pipetted in a volume of 50 μΐ on Schleicher-
Schuell No. 2992 filter paper, dried at room temperature and stored
at 4 °C.
Immunoradiometr ic assay
Polystyrene tubes were pretreated with an aqueous solution of glu-
taraldehyde, 10 g/1, (Merck) for 4 hours. After washing with dis-
tilled water, 0.5 ml of a solution of monoclonal antibody TSH-51
in a concentration of 5 mg/1 in phosphate-buffered saline, pH 7.5,
was added and incubated overnight at room temperature. After sub-
sequent washing with phosphate-buffered saline, the remaining
binding sites were blocked by incubation with a 10% solution of
bovine serum in phosphate-buffered saline.
A 4 mm disc cut out of the blood spot and 200 μΐ of a solution of
125I labelled monoclonal antibody TSH-116 were added to these
tubes. The labelled antibody was dissolved in phosphate-buffered
saline containing 1 g/1 bovine serum albumin to give a total activity
of 60 000 counts per minute per tube. After an incubation for 2 h
at room temperature, both the solution and the disc were discarded,
the tubes were rinsed twice with phosphate-buffered saline and the
bound radioactivity counted in a gamma-counter. Both the stan-
dards and the samples were run in duplicate.
The detection limit was estimated by measuring the 0 mU/I stan-
dard in 15 tubes and calculating from the standard curve the con-
centration corresponding to the mean enlarged by two standard
deviations of the mean.
The standards containing 15, 30 and 80 mU/1 of thyrotropin were
measured in duplicate in five consecutive assays (inter-assay eval-
uation) and in twelve tubes in a single assay (intra-assay evalua-
tion). The mean and standard deviation were calculated and the
precision expressed as the coefficient of variation (standard devia-
tion in percent of the mean).
Luminescence immunoenzymometr ic assay
Monoclonal antibody TSH-51 was bound on the solid phase of
96-well white plates (Immunotech, Prague) according to the
method of Immunotech (European patent EP 0122 209 A I). A
4.8 mm disc cut out of the blood spot on filter paper and 100
μί of 200 mmol/1 citrate buffer, pH 5.7, were added to each
well. After shaking for 2 h at 37 °C, the discs were removed
and the wells washed once. Phosphate-buffered saline containing
the conjugate of the TSH-116 antibody with horseradish peroxi-
dase (150 μί), was added to the wells. The conjugate of the
antibody with horseradish peroxidase was prepared with the two-
step glutaraldehyde technique (15). After shaking for 2 h at
37 °C and subsequent washing, 200 μΐ of the signal solution
containing 1.95 mmol/1 hydrogen peroxide, 290 μιηοΐ/ΐ luminol
and 45 μπιοΙ/1 /7-iodophenol was added (16, 17). The intensity
of the light emitted was measured between 5 and 20 min on
the LIANA luminometer (Immunotech,, Prague).
The detection limit was estimated by measuring the 0 mU/I stan-
dard in 15 tubes and calculating from the calibration curve the
concentration corresponding to the mean enlarged by two standard
deviations of the mean.
The standards containing 15, 30 and 70 mU/1 of thyrotropin were
measured in duplicate in twenty consecutive assays (inter-assay
evaluation) and in twelve tubes in a single assay (intra-assay eval-
uation). The mean and standard deviation were calculated and the
precision expressed as the coefficient of variation (standard devia-
tion in percent of the mean). To estimate the precision profile, coef-
ficients of variation of 960 duplicates (standards, control and un-
known samples) measured in twenty assays were used. The mean
coefficients of variation were calculated for individual 5 mU/1 in-
tervals of thyrotropin concentration and plotted against the thyro-
tropin concentration in the range of 1 -200 mU/1. The curve was
fitted using the polynomic function of the 6th degree.
Results
Immunoradiometr ic assay
A typical standard curve of the immunoradiometric as-
say of thyrotropin is shown in figure 1. When the cali-
bration was extended to 1000 mU/1, no hook effect was
present and the signal continued to increase.
The detection limit was 1.0 mU/1. The results with blood
spots containing other hormones added are shown in ta-
ble 1.
The intra-assay and inter-assay precision for three con-
centrations of thyrotropin is shown in table 2.
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Fig. 1 Typical standard curve for the immunoradiometric assay
of thyrotropin from dried blood spots.
The curve is fitted by the spline smoothed method. On the ordinate:
measured radioactivity in counts per minute, logarithmic scale. On
the abscissa: log of concentrations of thyrotropin standards.
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Luminescence immunoenzymometric assay
A typical standard curve of the luminescence immu-
noenzymometric assay of thyrotropin is shown in figure
2. The light intensity proved to increase up to a thyrotro-
pin concentration of 1100 mU/1. The detection limit was
2.4 mU/1.
The intra-assay and inter-assay precision for three con-
centrations of thyrotropin is shown in table 2. The
precision profile is shown in figure 3. The functional
detection limit, defined as the concentration of thyrotro-
pin measured with imprecision less than 15 percent, was
12 mU/1.
Thanks to the Prague Neonatal Screening Centre we
were able to use the present luminescence immunoenzy-
mometric method on blood spots from 3000 neonates
that had been screened for neonatal hypothyroidism by
Tab. 1 Levels of thyrotropin determined in blood spots with the
known concentration of hormone standards.
·£ 1OOOO
Possible interferent Human
thyro-
tropin
(mU/1)
Measured
value of human
thyrotropin
(mU/1)
Human chorionic gonadotropin
100U/1 0
100U/1 36
Human lutropin
100 U/l 0
100U/1 36
Human follitropin
100 U/l 0
100 U/l 36
Human prolactin
200 μg/l 0
200 μ§/1 36
Human somatotropin
100μ§/1 Ο
100 μ§/1 36
38.1
1.3
38.7
37.0
2.3
35.6
34.8
Tab. 2 The precision of measurement expressed as the infra-assay
and inter-assay coefficients of variation.
Thyrotropin
concentration
(mU/1)
Coefficient of variation in %
Intra-assay Inter-assay
Immunoradiometric assay
15 8.3
30 8.1
80 7.0
Luminescence immunoenzymometric assay
15 8.6
30 6.8
70 7.1
9.3
8.7
5.0
12.4
8.2
5.5
φ ·£
»
1000
300
10 100
Thyrotropin [mU/l]
Fig. 2 Typical standard curve for the luminescence immuno-
enzymometric assay of thyrotropin from dried blood spots.
The curve is fitted by the spline smoothed method. On the ordinate:
measured light intensities in relative light units, logarithmic scale.
On the abscissa: log of concentrations of thyrotropin standards.
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Fig. 3 Precision profile of the present luminescence immunoen-
zymometric assay.
The curve is fitted using the polynomic function of the 6th degree.
On the ordinate: mean coefficient of variation in percent. On the
abscissa: measured thyrotropin concentration.
methods including the Pharmacia Dry Spot TSH IRMA
kit in the preceding three years. Positive samples were
preferentially included. The concentration of thyrotropin
in the vast majority of all samples under comparison
proved to be lower than 20 mU/l (the cut-off level for
positives used in the Screening Centre) by both methods.
Higher concentrations were found in 15 cases by the
present luminescence immunoenzymometric method
and in 16 cases by the Dry Spot TSH IRMA method.
The only differing sample value could not be classified
as controversial, because both values (20.2 mU/l for
IRMA and 16.6mU/l for luminescence immunoenzy-
mometric assay) were very close to the cut-off border
value of 20 mU/l. To perform a more exact comparison
of the two methods, various amounts of thyrotropin were
added to 32 control blood samples up to a concentration
of 200 mU/l, the samples were assayed simultaneously
with both kits and the values obtained were studied by
the x/y method. The result is presented in figure 4. The
mean x/y was 0.982 and the coefficient of variation was
14.1 percent.
Discussion
The immunoradiometric assay for the determination of
thyrotropin from dried blood spots described in this pa-
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Fig. 4 Correlation between thyrotropin concentrations measured
by our luminescence immunoenzymometric assay (LIEMA) and
by the Pharmacia Dry Spot TSH IRMA kit (IRMA). On the ordi-
nate: ratio LIEMA/IRMA. On the abscissa: thyrotropin concentra-
tion measured by the Dry Spot TSH IRMA kit. The mean ratio
was 0.982 and the coefficient of variation was 14.10.
per is simple, easy to perform and rapid. The detection
limit of 1 mU/l is quite sufficient, as the levels below
20 mU/l are considered negative in the screening of neo-
natal hypothyroidism (18). A very low detection limit
(0.037 mU/l) was described in an assay of Japanese re-
searchers based on a combination of monoclonal anti-
body and polyclonal antibody (6). However, sensitivity
in this range is not necessary for the screening of pri-
mary hypothyroidism. The continuing increase of the
standard curve up to 1000 mU/l is more than adequate.
In spite of the fact that the labelled antibody used cross-
reacted with other glycoprotein hormones, the results
were not influenced by the presence of 100 U/l each of
lutropin, follitropin and chorionic gonadotropin. These
levels are not exceeded in the blood of neonates (6).
However, the immunoradiometric assay for thyrotropin
served only as the springboard for the development of
the luminescence immunoenzymometric assay for clin-
ical purposes and for this reason we have not examined
any real patient samples.
The advantage of the luminescence immunoenzymomet-
ric assay is the longer stability of the labelled antibody
and that its use is not limited to isotope laboratories. It
was not, however, possible to perform it in a one-step
modification, because the enzymatic reaction was influ-
enced by the presence of blood. Therefore it was neces-
sary to perform a two-step method and to add one more
wash. The precision seems to be comparable with the
IRMA method; the detection limit is somewhat higher
because of the higher signal of the zero standard (blank),
but sufficient for the neonatal screening. In comparison
with the immunochemiluminometric screening method
used by Neto (10) the procedure described is simpler,
because it is not necessary to pre-elute the disc, and
more rapid, because no overnight incubation is neces-
sary. There was no false positive result with real patient
samples and the cases of neonatal hypothyroidism were
properly recognized.
Conclusion
The conditions and properties of the immunoradiometric
and luminescence immunoenzymometric assays de-
scribed are adequate for the screening of neonatal hypo-
thyroidism. They are comparable with the time-resolved
immunofluorometric assay widely used in Europe (7, 8).
The luminescence immunoenzymometric assay was ap-
plied successfully in the screening of 3000 neonates for
congenital hypothyroidism.
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